Finance

Lists
190A:TYO
Chordia Therapeutics Inc
58,00 JP¥
+1,75%
(+1,00) 1D
13 қаз., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 190A...
Open
58 JP¥
High
59 JP¥
Low
57 JP¥
Mkt. cap
4,49 млрд
Avg. vol.
593,41 м.
Volume
202,90 м.
52-wk high
179 JP¥
52-wk low
56 JP¥
EPS
-20 JP¥
No. of employees
20
Open
58 JP¥
High
59 JP¥
Low
57 JP¥
Mkt. cap
4,49 млрд
Avg. vol.
593,41 м.
Volume
202,90 м.
52-wk high
179 JP¥
52-wk low
56 JP¥
EPS
-20 JP¥
No. of employees
20
News stories
From web sources and news partners
About Chordia Therapeutics Inc
CEO-
Employees20
Founded2017 ж. 12 қаз.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. там.
2025 ж. қар.
2026 ж. ақп.
2026 ж. мам.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
299,45 млн
229,68 млн
280,65 млн
331,16 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,46 млн
76,58 млн
75,81 млн
76,81 млн
Operating expense
368,90 млн
306,26 млн
356,47 млн
407,97 млн
Total operating expenses
368,90 млн
306,26 млн
356,47 млн
407,97 млн
Operating income
-368,90 млн
-306,26 млн
-356,47 млн
-407,97 млн
Other non operating income
-13,68 млн
16,43 млн
18,16 млн
-2,17 млн
EBT including unusual items
-385,91 млн
-294,85 млн
-337,91 млн
-413,51 млн
EBT excluding unusual items
-385,91 млн
-294,85 млн
-337,91 млн
-413,51 млн
Income tax expense
605,00 м.
475,00 м.
475,00 м.
475,00 м.
Effective tax rate
-0,16%
-0,16%
-0,14%
-0,11%
Other operating expenses
-
-
-
-
Net income
-386,52 млн
-295,32 млн
-338,38 млн
-413,98 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-368,23 млн
-305,58 млн
-355,79 млн
-407,29 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары